Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trialsGuy Young, Johnny Mahlangu, Lisa N Boggio, et al.
Blood Advances|December 9, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapyAnnette von Drygalski, Esteban Gomez, Adam Giermasz, et al.
Research and Practice in Thrombosis and Haemostasis|June 6, 2024
Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assaysKenneth D Friedman, Martina Böhm-Weigert, Nicole DeSimone, et al.
Chest|April 12, 2022
Defibrotide Therapy for SARS-CoV-2 ARDSDavid Frame, Gianni B Scappaticci, Thomas M Braun, et al.
Blood|December 21, 2023
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trialSteven W Pipe, Peter Collins, Christophe Dhalluin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 27, 2025
Operationalising a Haemophilia Gene Editing Lexicon for Practical UseWilliam McKeown, Cedric Hermans, Carmen Unzu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2007
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII geneLingxia Chen, Fuxiang Zhu, Juan Li, et al.
Research and Practice in Thrombosis and Haemostasis|February 27, 2026
Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trialRobert Klamroth, Paul E Monahan, Paul Van der Valk, et al.
The Lancet. Haematology|April 21, 2019
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 studySteven W Pipe, Midori Shima, Michaela Lehle, et al.
Nature Genetics|April 30, 2003
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complexBin Zhang, Michael A Cunningham, William C Nichols, et al.
Pageof 11